Cargando…

Refining the DC-targeting vaccination for preventing emerging infectious diseases

The development of safe, long-term, effective vaccines is still a challenge for many infectious diseases. Thus, the search of new vaccine strategies and production platforms that allow rapidly and effectively responding against emerging or reemerging pathogens has become a priority in the last years...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastor, Yadira, Ghazzaui, Nour, Hammoudi, Adele, Centlivre, Mireille, Cardinaud, Sylvain, Levy, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396646/
https://www.ncbi.nlm.nih.gov/pubmed/36016929
http://dx.doi.org/10.3389/fimmu.2022.949779
_version_ 1784771973286461440
author Pastor, Yadira
Ghazzaui, Nour
Hammoudi, Adele
Centlivre, Mireille
Cardinaud, Sylvain
Levy, Yves
author_facet Pastor, Yadira
Ghazzaui, Nour
Hammoudi, Adele
Centlivre, Mireille
Cardinaud, Sylvain
Levy, Yves
author_sort Pastor, Yadira
collection PubMed
description The development of safe, long-term, effective vaccines is still a challenge for many infectious diseases. Thus, the search of new vaccine strategies and production platforms that allow rapidly and effectively responding against emerging or reemerging pathogens has become a priority in the last years. Targeting the antigens directly to dendritic cells (DCs) has emerged as a new approach to enhance the immune response after vaccination. This strategy is based on the fusion of the antigens of choice to monoclonal antibodies directed against specific DC surface receptors such as CD40. Since time is essential, in silico approaches are of high interest to select the most immunogenic and conserved epitopes to improve the T- and B-cells responses. The purpose of this review is to present the advances in DC vaccination, with special focus on DC targeting vaccines and epitope mapping strategies and provide a new framework for improving vaccine responses against infectious diseases.
format Online
Article
Text
id pubmed-9396646
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93966462022-08-24 Refining the DC-targeting vaccination for preventing emerging infectious diseases Pastor, Yadira Ghazzaui, Nour Hammoudi, Adele Centlivre, Mireille Cardinaud, Sylvain Levy, Yves Front Immunol Immunology The development of safe, long-term, effective vaccines is still a challenge for many infectious diseases. Thus, the search of new vaccine strategies and production platforms that allow rapidly and effectively responding against emerging or reemerging pathogens has become a priority in the last years. Targeting the antigens directly to dendritic cells (DCs) has emerged as a new approach to enhance the immune response after vaccination. This strategy is based on the fusion of the antigens of choice to monoclonal antibodies directed against specific DC surface receptors such as CD40. Since time is essential, in silico approaches are of high interest to select the most immunogenic and conserved epitopes to improve the T- and B-cells responses. The purpose of this review is to present the advances in DC vaccination, with special focus on DC targeting vaccines and epitope mapping strategies and provide a new framework for improving vaccine responses against infectious diseases. Frontiers Media S.A. 2022-08-09 /pmc/articles/PMC9396646/ /pubmed/36016929 http://dx.doi.org/10.3389/fimmu.2022.949779 Text en Copyright © 2022 Pastor, Ghazzaui, Hammoudi, Centlivre, Cardinaud and Levy https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Pastor, Yadira
Ghazzaui, Nour
Hammoudi, Adele
Centlivre, Mireille
Cardinaud, Sylvain
Levy, Yves
Refining the DC-targeting vaccination for preventing emerging infectious diseases
title Refining the DC-targeting vaccination for preventing emerging infectious diseases
title_full Refining the DC-targeting vaccination for preventing emerging infectious diseases
title_fullStr Refining the DC-targeting vaccination for preventing emerging infectious diseases
title_full_unstemmed Refining the DC-targeting vaccination for preventing emerging infectious diseases
title_short Refining the DC-targeting vaccination for preventing emerging infectious diseases
title_sort refining the dc-targeting vaccination for preventing emerging infectious diseases
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396646/
https://www.ncbi.nlm.nih.gov/pubmed/36016929
http://dx.doi.org/10.3389/fimmu.2022.949779
work_keys_str_mv AT pastoryadira refiningthedctargetingvaccinationforpreventingemerginginfectiousdiseases
AT ghazzauinour refiningthedctargetingvaccinationforpreventingemerginginfectiousdiseases
AT hammoudiadele refiningthedctargetingvaccinationforpreventingemerginginfectiousdiseases
AT centlivremireille refiningthedctargetingvaccinationforpreventingemerginginfectiousdiseases
AT cardinaudsylvain refiningthedctargetingvaccinationforpreventingemerginginfectiousdiseases
AT levyyves refiningthedctargetingvaccinationforpreventingemerginginfectiousdiseases